+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Imricor Medical Systems Inc (IMR) - Product Pipeline Analysis, 2024 Update

  • PDF Icon

    Company Profile

  • 34 Pages
  • August 2024
  • GlobalData
  • ID: 5740099
Imricor Medical Systems Inc (Imricor Medical) is a medical device company that offers magnetic resonance imaging (MRI) equipment. The company's products include vision MR EP ablation catheter, advantage MR EP recorder and stimulator, vision MR dispersive electrode, among others. Its vision MR EP ablation catheter is used to operate in a magnetic resonance imaging (MRI) room. Advantage MR EP recorder and stimulator performs recording and pacing function of conventional recording and pacing systems. It markets its products across the US. The company has operations in the US, Australia, Germany, France, Switzerland, and the Netherlands. Imricor Medical is headquartered in Burnsville, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Imricor Medical Systems Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Imricor Medical Systems Inc Company Overview
  • Imricor Medical Systems Inc Company Snapshot
  • Imricor Medical Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Imricor Medical Systems Inc - Pipeline Analysis Overview
  • Imricor Medical Systems Inc - Key Facts
  • Imricor Medical Systems Inc - Major Products and Services
  • Imricor Medical Systems Inc Pipeline Products by Development Stage
  • Imricor Medical Systems Inc Ongoing Clinical Trials by Trial Status
  • Imricor Medical Systems Inc Pipeline Products Overview
  • Advantage-MR EP Recorder/Stimulator System
  • Advantage-MR EP Recorder/Stimulator System Product Overview
  • Advantage-MR EP Recorder/Stimulator System Clinical Trial
  • MRI-Compatible Defibrillator
  • MRI-Compatible Defibrillator Product Overview
  • NorthStar-MR 3D Mapping System
  • NorthStar-MR 3D Mapping System Product Overview
  • NorthStar-MR 3D Mapping System Clinical Trial
  • Vision-MR Ablation Catheter
  • Vision-MR Ablation Catheter Product Overview
  • Vision-MR Ablation Catheter 2.0
  • Vision-MR Ablation Catheter 2.0 Product Overview
  • Vision-MR Ablation Catheter 2.0 Clinical Trial
  • Vision-MR Diagnostic Catheter
  • Vision-MR Diagnostic Catheter Product Overview
  • Vision-MR Dispersive Electrode
  • Vision-MR Dispersive Electrode Product Overview
  • Imricor Medical Systems Inc - Key Competitors
  • Imricor Medical Systems Inc - Key Employees
  • Imricor Medical Systems Inc - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • Imricor Medical Systems Inc, Recent Developments
  • Aug 07, 2024: Johns Hopkins Treats First Patient in the United States as Part of Visabl-AFL Clinical Trial
  • Jun 28, 2024: Dubrava University Hospital Succesfully Performs Second Case And Reorders Consumables for Volume Ramp Up
  • Jun 26, 2024: Imricor Continues Geographic Expansion with New Customer Win in Hungary Adding Semmelweis Univeristy Hospital to the Growing iCMR Field
  • Jun 25, 2024: Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
  • Jun 21, 2024: VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
  • Jun 20, 2024: Imricor Procedures Commence at Dubrava University Hospital
  • May 09, 2024: Visabl-AFL Trial for US FDA Approval Receives Final Approval at Lausanne University Hospital in Switzerland
  • Apr 11, 2024: Imricor Receives First Catheter Order from Dubrava University Hospital
  • Mar 11, 2024: Visabl-AFL Trial for US FDA Approval Receives Ethics Approval at Cardiovascular Institute of South Paris
  • Mar 08, 2024: Visabl-Afl Trial for US FDA Approval Receives Ethics Approval at Lausanne University Hospital (CHUV)
  • Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Imricor Medical Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Imricor Medical Systems Inc Pipeline Products by Equipment Type
  • Imricor Medical Systems Inc Pipeline Products by Indication
  • Imricor Medical Systems Inc Ongoing Clinical Trials by Trial Status
  • Imricor Medical Systems Inc, Key Facts
  • Imricor Medical Systems Inc, Major Products and Services
  • Imricor Medical Systems Inc Number of Pipeline Products by Development Stage
  • Imricor Medical Systems Inc Pipeline Products Summary by Development Stage
  • Imricor Medical Systems Inc Ongoing Clinical Trials by Trial Status
  • Imricor Medical Systems Inc Ongoing Clinical Trials Summary
  • Advantage-MR EP Recorder/Stimulator System - Product Status
  • Advantage-MR EP Recorder/Stimulator System - Product Description
  • Advantage-MR EP Recorder/Stimulator System - Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter
  • MRI-Compatible Defibrillator - Product Status
  • MRI-Compatible Defibrillator - Product Description
  • NorthStar-MR 3D Mapping System - Product Status
  • NorthStar-MR 3D Mapping System - Product Description
  • NorthStar-MR 3D Mapping System - Assessing the Accuracy of Catheter Localization With NorthStar Software in Real-Time MRI-Guided Cardiac Ablation
  • NorthStar-MR 3D Mapping System - Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter
  • Vision-MR Ablation Catheter - Product Status
  • Vision-MR Ablation Catheter - Product Description
  • Vision-MR Ablation Catheter 2.0 - Product Status
  • Vision-MR Ablation Catheter 2.0 - Product Description
  • Vision-MR Ablation Catheter 2.0 - Vision-MR Ablation Catheter 2.0 for the Treatment of Ventricular Tachycardia
  • Vision-MR Ablation Catheter 2.0 - Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter
  • Vision-MR Diagnostic Catheter - Product Status
  • Vision-MR Diagnostic Catheter - Product Description
  • Vision-MR Dispersive Electrode - Product Status
  • Vision-MR Dispersive Electrode - Product Description
  • Imricor Medical Systems Inc, Key Employees
  • Glossary
List of Figures
  • Imricor Medical Systems Inc Pipeline Products by Equipment Type
  • Imricor Medical Systems Inc Pipeline Products by Development Stage
  • Imricor Medical Systems Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Varian Medical Systems Inc
  • Inspire Medical Systems Inc
  • Catheter Precision Inc
  • BioPhysics Assay Laboratory Inc
  • Amber Diagnostics Inc